Veradigm Inc
OTC:MDRX

Watchlist Manager
Veradigm Inc Logo
Veradigm Inc
OTC:MDRX
Watchlist
Price: 4.91 USD 0.2%
Market Cap: $534.7m

Net Margin

-14.7%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-14.7%
=
Net Income
$-86.5m
/
Revenue
$588m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-14.7%
=
Net Income
$-86.5m
/
Revenue
$588m

Peer Comparison

Country Company Market Cap Net
Margin
US
Veradigm Inc
OTC:MDRX
520.8m USD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
35.9B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
19.4B AUD
Loading...
JP
M3 Inc
TSE:2413
1.3T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.3B USD
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD
Loading...
SE
Sectra AB
STO:SECT B
43.7B SEK
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
25.6B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
272.9B INR
Loading...
US
Vocera Communications Inc
F:V00
2.4B EUR
Loading...

Market Distribution

Lower than 72% of companies in the United States of America
Percentile
28th
Based on 15 072 companies
28th percentile
-14.7%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Veradigm Inc
Glance View

Market Cap
534.7m USD
Industry
Health Care

Veradigm Inc., formerly known as Allscripts Healthcare Solutions, has carved out a distinct niche within the healthcare technology landscape. The company focuses on the dynamic intersection of technology and healthcare, developing an array of solutions aimed at enhancing healthcare delivery and efficiency. Essentially, Veradigm equips medical professionals with tools for electronic health records, practice management, and remote patient monitoring. By leveraging sophisticated information systems, Veradigm helps streamline operations in doctor's offices, hospitals, and healthcare organizations, making it easier for healthcare providers to deliver efficient and effective services. Their products are designed not only to improve clinical workflows but also to enhance patient engagement, ultimately leading to better health outcomes. The revenue model of Veradigm hinges largely on contractual agreements and subscriptions for its software solutions. By offering a range of cloud-based services, the company ensures a steady flow of recurrent income while reducing the need for expensive on-site installations, thus delivering value to both large hospital systems and smaller, private practices. Additionally, Veradigm has diversified its revenue streams through collaborations with pharmaceutical companies, providing data insights and support for research and marketing initiatives. With a persistent focus on innovation and adaptability, Veradigm not only strengthens its foundational business in healthcare IT but also taps into new opportunities within the emerging landscape of digital health and data analytics.

MDRX Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-14.7%
=
Net Income
$-86.5m
/
Revenue
$588m
What is Veradigm Inc's current Net Margin?

The current Net Margin for Veradigm Inc is -14.7%, which is in line with its 3-year median of -14.7%.

How has Net Margin changed over time?

Over the last 3 years, Veradigm Inc’s Net Margin has decreased from -11.2% to -14.7%. During this period, it reached a low of -14.7% on Jan 31, 2023 and a high of 111.1% on Sep 30, 2021.

Back to Top